All data are based on the daily closing price as of June 6, 2025
u
Universal Vision Biotechnology
3218.TWO
6.82 USD
-0.10
-1.45%
Overview
Last close
6.82 usd
Market cap
577.42M usd
52 week high
9.36 usd
52 week low
4.85 usd
Target price
7.1 usd
Valuation
P/E
15.4312
Forward P/E
N/A
Price/Sales
4.038
Price/Book Value
5.1497
Enterprise Value
531.11M usd
EV/Revenue
3.7125
EV/EBITDA
8.1456
Key financials
Revenue TTM
143.06M usd
Gross Profit TTM
84.85M usd
EBITDA TTM
59.18M usd
Earnings per Share
0.44 usd
Dividend
0.25 usd
Total assets
186.94M usd
Net debt
N/A usd
About
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers eye plastic and micro cosmetic surgery; and aesthetic medicine consulting services, and provides nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.